The Kendall Square Founders Brief
The Kendall Square Founders Brief from Lanton, Lanton & Sosa Law examines the legal and business decisions facing biotechnology companies in Cambridge and Greater Boston, including employment law, laboratory leases, pharmaceutical pricing, financing and transaction readiness.
New York Life Sciences Founders Brief
Growing a life-sciences company in New York requires decisions beyond the laboratory. The New York Life Sciences Founders Brief from Lanton, Lanton & Sosa Law examines employment law, laboratory leases, state tax incentives, regulatory policy and transaction readiness for biotechnology founders and executives.
COINS and Biotech: The Deal Structure May Matter More Than the License
Treasury’s proposed COINS rules may leave traditional pharma licensing outside core restrictions while creating new questions for equity, joint-venture and NewCo deals.
Could Switzerland Be Next? U.S. Drug Pricing Pressure Expands Beyond Germany
U.S. scrutiny of German drug pricing could extend to Switzerland and France. Ron Lanton examines how trade investigations, pharmaceutical pricing agreements, and tariffs may affect market access, launch decisions, and international commercialization.
PhRMA’s GLOBE Lawsuit: What the Case Could Mean for Medicare Drug Pricing
PhRMA’s GLOBE lawsuit challenges CMS authority to link Medicare Part B drug rebates to international prices. Here is what manufacturers and providers should watch.
Kendall Square Lab Space: What Life Sciences Companies Should Consider Before Signing Their Next Lease
Kendall Square remains a global life sciences hub, but the market for laboratory space has changed. Greater availability is giving companies an opportunity to look beyond rent and negotiate for greater flexibility in buildouts, assignments, expansion rights and future transactions.
AI + Healthcare, Part 3: AI’s Next Phase Is About Control, Not Speed
AI’s next phase will be defined not only by technical speed, but by governance, data protection, accountability and measurable value.